- Home
- CISO vs ATHE Comparison
CISO vs ATHE Comparison
Compare CISO & ATHE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CISO
- ATHE
- Stock Information
- Founded
- CISO 2015
- ATHE 1997
- Country
- CISO United States
- ATHE Australia
- Employees
- CISO N/A
- ATHE N/A
- Industry
- CISO Computer Software: Prepackaged Software
- ATHE Biotechnology: Pharmaceutical Preparations
- Sector
- CISO Technology
- ATHE Health Care
- Exchange
- CISO Nasdaq
- ATHE Nasdaq
- Market Cap
- CISO 12.5M
- ATHE 10.1M
- IPO Year
- CISO N/A
- ATHE N/A
- Fundamental
- Price
- CISO $1.55
- ATHE $2.16
- Analyst Decision
- CISO
- ATHE Strong Buy
- Analyst Count
- CISO 0
- ATHE 2
- Target Price
- CISO N/A
- ATHE $6.00
- AVG Volume (30 Days)
- CISO 122.5K
- ATHE 118.8K
- Earning Date
- CISO 11-18-2024
- ATHE 12-24-2024
- Dividend Yield
- CISO N/A
- ATHE N/A
- EPS Growth
- CISO N/A
- ATHE N/A
- EPS
- CISO N/A
- ATHE N/A
- Revenue
- CISO $54,633,909.00
- ATHE $2,681,669.00
- Revenue This Year
- CISO $78.76
- ATHE N/A
- Revenue Next Year
- CISO N/A
- ATHE N/A
- P/E Ratio
- CISO N/A
- ATHE N/A
- Revenue Growth
- CISO 34.87
- ATHE 2.63
- 52 Week Low
- CISO $0.26
- ATHE $1.00
- 52 Week High
- CISO $3.60
- ATHE $3.19
- Technical
- Relative Strength Index (RSI)
- CISO 59.64
- ATHE 64.93
- Support Level
- CISO $1.50
- ATHE $2.18
- Resistance Level
- CISO $1.73
- ATHE $2.45
- Average True Range (ATR)
- CISO 0.19
- ATHE 0.25
- MACD
- CISO -0.00
- ATHE 0.03
- Stochastic Oscillator
- CISO 45.08
- ATHE 74.63
About CISO CISO Global Inc.
CISO Global Inc provides cybersecurity services. The services are used to protect client's data, financial information, intellectual property, and business reputation. The services include penetration testing, security remediation, compliance auditing, vulnerability assessment, and others. Geographically, the company operates in U.S., Chile and All other countries. The maximum revenue is generated from U.S.
About ATHE Alterity Therapeutics Limited
Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaborations for the treatment of Parkinsonian movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company's drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has a drug candidate for Parkinson's disease and other movement disorders (ATH434). The Group operated in one segment, being researching and developing Parkinsonian and other neurodegenerative disorders.